Comparing two spleen-saving surgeries for pancreatic tumors
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial compares two laparoscopic techniques to remove tumors from the pancreas while keeping the spleen. The goal is to see which method is safer and better for people with non-cancerous or low-grade tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have a benign (non-cancerous) or low-grade malignant tumor in the pancreas.
- Your doctor has confirmed that surgery is needed and that you can have one of the two spleen-preserving procedures.
- You are generally healthy, with a performance status of 0 or 1 (able to carry out daily activities without significant limitations).
- You are not overweight (BMI of 28 or less).
- You have no history of abdominal surgery, blood disorders, pancreatitis, or other serious conditions listed in the study exclusions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two surgical approaches for removing tumors in the head of the pancreas or nearby areas: 'keyhole' (laparoscopic) surgery versus traditional open surgery. The goal is to see if the keyhole method offers similar results with a faster recovery.
This study compares two ways to remove a tumor from the left side of the pancreas: one that also removes the spleen, and one that tries to keep the spleen. Keeping the spleen may lower the risk of infections later, but the trial will check if it is as safe and effective as removing it.
This trial compares a modified surgical technique to the standard one for removing pancreatic tumors. It aims to see if the new method lowers the risk of a leak from the pancreas after surgery.
This trial compares two types of surgery to remove tumors that start near the pancreas but not in it. The goal is to see if a newer, less invasive method works as well as the standard approach, which may mean fewer cuts and a faster recovery.
This trial compares two ways of doing the same surgery to remove a tumor in the pancreas. It looks at whether removing the blood supply to the tumor first makes the surgery safer or more effective than the usual method.
This trial compares two standard surgical techniques for removing pancreatic head tumors: the usual surgery (partial pancreatoduodenectomy) versus a more extended version that removes additional tissue. The goal is to see which approach offers better outcomes for patients, potentially improving survival or reducing recurrence.
Hear when a new Pancreatic Neuroendocrine Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.